Denosumab for craniofacial fibrous dysplasia: duration of efficacy and post-treatment effects
Layne N. Raborn, Andrea B. Burke, David H. Ebb, Michael T. Collins, Leonard B. Kaban, Alison M Boyce
Topics & Concepts
DenosumabMedicineDiscontinuationFibrous dysplasiaCraniofacialBone remodelingLesionDysplasiaInternal medicineSurgeryOsteoporosisPsychiatryBone Tumor Diagnosis and TreatmentsOral and Maxillofacial PathologyBone health and treatments